SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis

Ratnakumar, S; Hayward, SE; Denneny, EK; Goldsmith, LP; Evans, R; Checkley, W; Goletti, D; Ong, CWM; Gotowiec, M; Zhu, J; et al. Ratnakumar, S; Hayward, SE; Denneny, EK; Goldsmith, LP; Evans, R; Checkley, W; Goletti, D; Ong, CWM; Gotowiec, M; Zhu, J; Friedland, JS; Porter, JC (2025) Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis. The Lancet Global Health, 13 (6). e1020-e1029. ISSN 2214-109X https://doi.org/10.1016/s2214-109x(25)00105-6
SGUL Authors: Friedland, Jonathan Samuel

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (634kB)
[img] PDF (Supplementary appendix) Supporting information
Download (623kB)

Abstract

Background Although post-tuberculosis lung disease poses a substantial threat to individuals who have recovered from pulmonary tuberculosis, data showing objective functional impairment in such people are scarce. We did a systematic review and meta-analysis to estimate respiratory impairment after pulmonary tuberculosis disease and examine differences in ventilatory defects. Methods We systematically searched Embase, MEDLINE, and CINAHL from Jan 1, 2000, to Dec 13, 2024. We included any study design with data on lung function tests in individuals with a previous diagnosis of pulmonary tuberculosis versus healthy controls. Outcomes extracted from eligible studies included forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1 as a percentage of the predicted value (FEV1%), FVC as a percentage of the predicted value (FVC%), and FEV1/FVC ratio. Pre-bronchodilator values were preferentially selected. Random effects mean difference models were used when possible and standardised mean difference where it was necessary to standardise to a single scale (ie, FEV1%, FVC%, and FEV1/FVC ratio). Between-study heterogeneity was estimated with I2. This study was prospectively registered with PROSPERO (CRD42021248838). Findings Of the 5594 publications found, data from 19 studies were included for meta-analyses, reporting on 75 960 individuals of whom 7447 had past pulmonary tuberculosis. All studies reporting absolute values, using various levels of adjustment or standardisation, showed that previous pulmonary tuberculosis had a negative effect across all spirometric values: FEV1 –0·41 L (95% CI –0·51 to –0·32, I2=90·4%), FVC –0·25 L (–0·33 to –0·17, I2=80·6%), and FEV1/FVC ratio –0·37 (–0·54 to –0·19, I2=92·0%). In those studies, using reference values to derive FEV1% and FVC %, prior pulmonary tuberculosis had a pooled standardised mean difference of –0·44 (–0·60 to –0·28, I2=95·6%) and –0·33 (–0·54 to –0·13, I2=91·3%), respectively, compared with controls. Interpretation People who recover from pulmonary tuberculosis have significantly decreased lung function compared with controls, with FEV1 more affected than FVC, giving a mixed obstructive and restrictive picture with predominantly airflow obstruction. Funding Breathing Matters.

Item Type: Article
Additional Information: Copyright © 2025 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Journal or Publication Title: The Lancet Global Health
ISSN: 2214-109X
Language: en
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDBreathing MattersUNSPECIFIED
UNSPECIFIEDUCL RespiratoryUNSPECIFIED
UNSPECIFIEDThe Mason Medical Research FellowshipUNSPECIFIED
MR/N013638/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
NIHR206676National Institute for Health and Care Researchhttps://doi.org/10.13039/501100000272
UNSPECIFIEDItalian Ministry of HealthUNSPECIFIED
CSAINV21nov-0003National Medical Research Councilhttp://dx.doi.org/10.13039/501100001349
CIRG21jun-0004National Medical Research Councilhttp://dx.doi.org/10.13039/501100001349
UNSPECIFIEDNational Institute of Health and Care Research (NIHR) University College London Hospitals Biomedical Research CentreUNSPECIFIED
URI: https://openaccess.sgul.ac.uk/id/eprint/117548
Publisher's version: https://doi.org/10.1016/s2214-109x(25)00105-6

Actions (login required)

Edit Item Edit Item